Other in vitro studies however showed that mTOR inhibition under hypoxic conditions can promote survival of glioma cell lines in vitro by reducing oxygen and glucose consumption, and promotes temozolomide resistance by increasing MGMT protein levels (75, 76). The gene discussed is MGMT; the disease is central nervous system cancer.